Old world cutaneous leishmaniasis in Iran: clinical variants and treatments

References

• Khosravi A, Sharifi I, Fekri A, et al. Clinical features of anthroponotic cutaneous leishmaniasis in a major focus, Southeastern Iran, 1994–2014. Iran J Parasitol. 2017;12(4):544.
   PubMed Web of Science ®Google Scholar
• Moradzadeh R, Golmohammadi P, Ashraf H, et al. Effectiveness of paromomycin on cutaneous leishmaniasis in Iran: a systematic review and meta-analysis. Iran J Med Sci. 2019;44(3):185.
   PubMed Web of Science ®Google Scholar
• Khatami A, Firooz A, Gorouhi F, et al. Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials. J Am Acad Dermatol. 2007;57(2):335. e1–335. e29.
   Web of Science ®Google Scholar
• Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Amsterdam, The Netherlands: Elsevier; 2019.
   Google Scholar
• Akilov OE, Khachemoune A, Hasan T. Clinical manifestations and classification of Old World cutaneous leishmaniasis. Int J Dermatol. 2007;46(2):132–142.
   PubMed Web of Science ®Google Scholar
• Aronson NE, Joya CA. Cutaneous leishmaniasis: updates in diagnosis and management. Infect Dis Clin. 2019;33(1):101–117.
   PubMed Web of Science ®Google Scholar
• Mortazavi H, Sadeghipour P, Taslimi Y, et al. Comparing acute and chronic human cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica focusing on arginase activity. J Eur Acad Dermatol Venereol. 2016;30(12):2118–2121.
   PubMed Web of Science ®Google Scholar
• Handler MZ, Patel PA, Kapila R, et al. Cutaneous and mucocutaneous leishmaniasis: differential diagnosis, diagnosis, histopathology, and management. J Am Acad Dermatol. 2015;73(6):911–926.
   PubMed Web of Science ®Google Scholar
• Heras‐Mosteiro J, Monge‐Maillo B, Pinart M, et al. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev. 2017;(11):CD005067.
   Web of Science ®Google Scholar
• Asilian A, Sadeghinia A, Faghihi G, et al. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime®) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime®) alone for the treatment of cutaneous leishmaniasis. Int J Dermatol. 2004;43(4):281–283.
   PubMed Web of Science ®Google Scholar
• Mohebali M, Fotouhi A, Hooshmand B, et al. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran. Acta Trop. 2007;103(1):33–40.
   PubMed Web of Science ®Google Scholar
• Nassiri‐Kashani M, Firooz A, Khamesipour A, et al. A randomized, double‐blind, placebo‐controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis. J Eur Acad Dermatol Venerol. 2005;19(1):80–83.
   PubMed Web of Science ®Google Scholar
• Emad M, Hayati F, Fallahzadeh MK, et al. Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: a randomized clinical trial. J Am Acad Dermatol. 2011;64(3):606–608.
   PubMed Web of Science ®Google Scholar
• Farajzadeh S, Esfandiarpour I, Haghdoost AA, et al. Comparison between combination therapy of oral terbinafine and cryotherapy versus systemic meglumine antimoniate and cryotherapy in cutaneous leishmaniasis: a randomized clinical trial. Iran J Parasitol. 2015;10(1):1
   PubMed Web of Science ®Google Scholar
• Firooz A, Khamesipour A, Ghoorchi MH, et al. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial. Arch Dermatol. 2006;142(12):1575–1579.
   PubMed Web of Science ®Google Scholar
• Shazad B, Abbaszadeh B, Khamesipour A. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major. Eur J Dermatol. 2005;15(2):85–87.
   PubMed Web of Science ®Google Scholar
• Parvizi MM, Handjani F, Moein M, et al. Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: a triple-blind randomized controlled clinical trial. PLoS Negl Trop Dis. 2017;11(10):e0005957.
   PubMed Web of Science ®Google Scholar
• Momeni A, Aminjavaheri M. Clinical picture of cutaneous leishmaniasis in Isfahan, Iran. Int J Dermatol. 1994;33(4):260–265.
   PubMed Web of Science ®Google Scholar
• Omidian M, Mapar M. Chronic zosteriform cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol. 2006;72(1):41.
   PubMedGoogle Scholar
• Zerehsaz F, Beheshti S, Reza G, et al. Erysipeloid cutaneous leishmaniasis: treatment with a new, topical, pure herbal extract. Eur J Dermatol. 2003;13(2):145–148.
   PubMed Web of Science ®Google Scholar
• Zerehsaz F, Salmanpour R, Handjani F, et al. A double‐blind randomized clinical trial of a topical herbal extract (Z‐HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran. Int J Dermatol. 1999;38(8):610–612.
   PubMed Web of Science ®Google Scholar
• Bari AU, Rahman SB. Many faces of cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol. 2008;74(1):23.
   PubMed Web of Science ®Google Scholar
• Solomon M, Greenberger S, Baum S, et al. Unusual forms of cutaneous leishmaniasis due to Leishmania major. J Eur Acad Dermatol Venereol. 2016;30(7):1171–1175.
   PubMed Web of Science ®Google Scholar
• Doudi M, Setorki M, Narimani M. Bacterial superinfection in zoonotic cutaneous leishmaniasis. Med Sci Monit. 2012;18(9):BR356.
   PubMed Web of Science ®Google Scholar
• Mortazavi H, Azadeh B. Localized leishmania lymphadenitis. Gulf J Dermatol Venereol. 2000;7(1):2.
   Google Scholar
• Sadeghi-Hasanabadi A, Nader K, Abdollahi B, et al. An outbreak of leishmaniasis with unusual presentation in Shiraz, Iran. Trans R Soc Trop Med Hyg. 1987;81(3):359.
   PubMed Web of Science ®Google Scholar
• Dabiri S, Meymandi S, Nadji M, et al. A description of parasite-harbouring cells in localized lymphadenitis in dry type cutaneous leishmaniasis. Acta Trop. 2001;79(2):129–133.
   PubMed Web of Science ®Google Scholar
• Azadeh B. Localized leishmania lymphadenitis: a light and electron microscopic study. Am J Trop Med Hyg. 1985;34(3):447–455.
   PubMed Web of Science ®Google Scholar
• Ardehali S, Sadeghi-Hassanabadi A, Moaddeb A, et al. The characterization of Leishmania from patients with lymphadenopathy in Shiraz, Iran. Trans R Soc Trop Med Hyg. 1995;89(4):370–371.
   PubMed Web of Science ®Google Scholar
• Esfandiarpour I, Dabiri S, Yousefi K. Dry type leishmanial lymphadenitis presented as two large parotid and cervical masses. Int J Dermatol. 2007;46(7):711–714.
   PubMed Web of Science ®Google Scholar
• Ayatollahi J. Sporotrichoid cutaneous leishmaniasis in Central Iran. Iran J Med Sci. 2006;31(3)173–175.
   Google Scholar
• Benzaquen M, Chambelland A, Fongue J, et al. Cutaneous sporotrichoid leishmaniasis treated with oral fluconazole. Dermatol Ther. 2019;31:e12976.
   Google Scholar
• Ziai M, Bowman J, McMillan C, et al. Leishmaniasis in Southern Iran: the occurrence of all three varieties in the same area. Trans R Soc Trop Med Hyg. 1968;62(5):668–671.
   PubMed Web of Science ®Google Scholar
• Hajjaran H, Mahdi M, Mohebali M, et al. Detection and molecular identification of leishmania RNA virus (LRV) in Iranian Leishmania species. Arch Virol. 2016;161(12):3385–3390.
   PubMed Web of Science ®Google Scholar
• Mortazavi H, Mohebali M, Taslimi Y, et al. Hoarseness as the presenting symptom of visceral leishmaniasis with muco-cutaneous lesions: a case report. Iran J Parasitol. 2015;10(2):296.
   PubMed Web of Science ®Google Scholar
• Mosimann V, Blazek C, Grob H, et al., editors. Miltefosine for mucosal and complicated cutaneous old world leishmaniasis: a case series and review of the literature. Open Forum Infect Dis. 2016;3(1):ofw008.
   Google Scholar
• Sharifi I, Fekri A, Aflatoonian M, et al. Leishmaniasis recidivans among school children in Bam, South‐east Iran, 1994–2006. Int J Dermatol. 2010;49(5):557–561.
   PubMed Web of Science ®Google Scholar
• Griffiths C, Barker J, Bleiker T, et al. Rook's textbook of dermatology. Hoboken, NJ: John Wiley and Sons; 2016.
   Google Scholar
• Pettit JH. Letter from Shiraz. Br J Dermatol. 1962;74(4):149–152.
   PubMedGoogle Scholar
• Dowlati Y. Cutaneous leishmaniasis: clinical aspect. Clin Dermatol. 1996;14(5):425–431.
   PubMed Web of Science ®Google Scholar
• Esfandiarpour I, Dabiri SH. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study. Int J Dermatol. 2007;46(8):848–852.
   PubMed Web of Science ®Google Scholar
• Momeni AZ, Aminjavaheri M. Successful treatment of nonhealing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol. Eur J Dermatol. 2003;13(1):40–43.
   PubMed Web of Science ®Google Scholar
• Nilforoushzadeh MA, Sadeghian G, Jaffary F, et al. Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report). Korean J Parasitol. 2008;46(3):175.
   PubMed Web of Science ®Google Scholar
• Khamesipour A, Dowlati Y, Asilian A, et al. Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine. 2005;23(28):3642–3648.
   PubMed Web of Science ®Google Scholar
• Mohebali M, Nadim A, Khamesipour A. An overview of leishmanization experience: a successful control measure and a tool to evaluate candidate vaccines. Acta Trop. 2019;200:105173.
   PubMed Web of Science ®Google Scholar
• Nadim A, Javadian E, Mohebali M. The experience of leishmanization in the Islamic Republic of Iran. East Mediterranean Health J. 1997;3(2):284–289.
   Google Scholar
• Khamesipour A, Abbasi A, Firooz A, et al. Treatment of cutaneous lesion of 20 years’ duration caused by leishmanization. Indian J Dermatol. 2012;57(2):123.
   PubMedGoogle Scholar
• Hashiguchi Y, Gomez EL, Kato H, et al. Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review. Trop Med Health. 2016;44(1):2.
   PubMedGoogle Scholar
• Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4th ed. Edinburg, London: Elsevier Health Sciences; 2018.
   Google Scholar
• Aghaei S, Salmanpour R, Handjani F, et al. Ulcerated disseminated cutaneous leishmaniasis associated with vitiligo, hypothyroidism, and diabetes mellitus in a patient with Down syndrome. Dermatol Online J. 2004;10(2):21.
   PubMedGoogle Scholar
• Alborzi A, Pouladfar GR, Fakhar M, et al. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. Am J Trop Med Hyg. 2008;79(3):435–437.
   PubMed Web of Science ®Google Scholar
• Hajjaran H, Mohebali M, Akhavan A, et al. Unusual presentation of disseminated cutaneous leishmaniasis due to Leishmania major: case reports of four Iranian patients. Asian Pacific J Trop Med. 2013;6(4):333–336.
   PubMed Web of Science ®Google Scholar
• Razeghinejad MR, Monabati A, Kadivar MR, et al. Conjunctival leishmaniasis in a case of disseminated cutaneous leishmaniasis. Trop Doct. 2017;47(1):53–55.
   PubMed Web of Science ®Google Scholar
• Hashemi SA, Badirzadeh A, Sabzevari S, et al. First case report of atypical disseminated cutaneous leishmaniasis in an opium abuser in Iran. Rev Inst Med Trop S Paulo. 2018;60(0):e5.
   PubMedGoogle Scholar
• Hamzavi SS, Sanaei Dashti A, Kadivar MR, et al. Successful treatment of disseminated cutaneous leishmaniasis with liposomal amphotericin B and miltefosine in an eight-year-old girl. Pediatr Infect Dis J. 2018;37(3):275–277.
   PubMed Web of Science ®Google Scholar
• Mortazavi H, Salehi M, Kamyab K. Reactivation of cutaneous leishmaniasis after renal transplantation: a case report. Case Rep Dermatol Med. 2014;2014:1.
   Google Scholar
• Czechowicz RT, Millard TP, Smith HR, et al. Reactivation of cutaneous leishmaniasis after surgery. Br J Dermatol. 1999;141(6):1113–1116.
   PubMed Web of Science ®Google Scholar
• Badirzadeh A, Mohebali M, Ghasemian M, et al. Cutaneous and post kala-azar dermal leishmaniasis caused by Leishmania infantum in endemic areas of visceral leishmaniasis, northwestern Iran 2002–2011: a case series. Pathog Global Health 2013;107(4):194–197.
   PubMed Web of Science ®Google Scholar
• Mortazavi H, Soori T, Khamesipour A, et al. Co-existence of cutaneous leishmaniasis with pleural effusion: a case report from Iran. Acta Med Iran. 2014;52(3):231–233.
   PubMedGoogle Scholar
• Pourahmad M, Hooshmand F, Rahiminejad M. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS). Int J Dermatol. 2009;48(1):59–61.
   PubMed Web of Science ®Google Scholar
• Badirzadeh A, Mohebali M, Sabzevari S, et al. Case report: first coinfection report of mixed leishmania infantum/leishmania major and human immunodeficiency virus–acquired immune deficiency syndrome: report of a case of disseminated cutaneous leishmaniasis in Iran. Am J Trop Med Hyg. 2018;98(1):122–125.
   PubMed Web of Science ®Google Scholar
• Bassiouny A, Meshad M, Talaat M, et al. Cryosurgery in cutaneous leishmaniasis. Br J Dermatol. 1982;107(4):467–474.
   PubMed Web of Science ®Google Scholar
• Alavi-Naini R, Fazaeli A, O'Dempsey T. Topical treatment modalities for old world cutaneous leishmaniasis: a review. Prague Med Rep. 2012;113(2):105–118.
   PubMedGoogle Scholar
• Pasquali P. Cryosurgery: a practical manual. Berlin Heidelberg: Springer; 2014.
   Google Scholar
• Handjani F, Yousef SR, Saki N, et al. Interleukin-10 and interferon-γ levels in patients with cutaneous leishmaniasis treated with cryotherapy. Iran J Med Sci. 2017;42(5):488.
   PubMed Web of Science ®Google Scholar
• Layegh P, Pezeshkpoor F, Soruri AH, et al. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children. Am J Trop Med Hyg. 2009;80(2):172–175.
   PubMed Web of Science ®Google Scholar
• David JR. The successful use of radiofrequency-induced heat therapy for cutaneous leishmaniasis: a review. Parasitology. 2018;145(4):527–536.
   PubMed Web of Science ®Google Scholar
• Sadeghian G, Nilfroushzadeh M, Iraji F. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate. Clin Exp Dermatol. 2007;32(4):371–374.
   PubMed Web of Science ®Google Scholar
• Kämink S, Abdi A, Kamau C, et al. Failure of an innovative low-cost, noninvasive thermotherapy device for treating cutaneous leishmaniasis caused by leishmania tropica in Pakistan. Am J Trop Med Hyg. 2019;101(6):1373–1379.
   PubMed Web of Science ®Google Scholar
• Rijal S, Chappuis F, Singh R, et al. Sodium stibogluconate cardiotoxicity and safety of generics. Trans R Soc Trop Med Hyg. 2003;97(5):597–598.
   PubMed Web of Science ®Google Scholar
• Sundar S, Sinha PR, Agrawal NK, et al. A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. Am J Trop Med Hyg. 1998;59(1):139–143.
   PubMed Web of Science ®Google Scholar
• Shirzadi MR. Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis. RRTM. 2019;10:11.
   Google Scholar
• Kang S. Fitzpatrick's dermatology. 9th ed. New York, NY: McGraw-Hill Education; 2018.
   Google Scholar
• Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 9th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2011.
   Google Scholar
• Najafian HR, Mohebali M, Rezayat SM, et al. Nanoliposomal miltefosine for the treatment of cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): the drug preparation and in vitro study. Int J Pharma Res Allied Sci. 2016;5(3):97–107.
   Web of Science ®Google Scholar
• Shirzadi M, Esfahania S, Mohebalia M, et al. Epidemiological status of leishmaniasis in the Islamic Republic of Iran, 1983-2012. Easter Mediterr Health J. 2015;21(10):736.
   PubMed Web of Science ®Google Scholar
• Ardehali S, Moattari A, Hatam G, et al. Characterization of Leishmania isolated in Iran: 1. Serotyping with species specific monoclonal antibodies. Acta Trop. 2000;75(3):301–307.
   PubMed Web of Science ®Google Scholar
• Shirian S, Oryan A, Hatam GR, et al. Three Leishmania/L. species–L. infantum, L. major, L. tropica–as causative agents of mucosal leishmaniasis in Iran. Pathog Global Health 2013;107(5):267–272.
   PubMed Web of Science ®Google Scholar
• Mohammadpour I, Motazedian MH, Handjani F, et al. Lip leishmaniasis: a case series with molecular identification and literature review. BMC Infect Dis. 2017;17(1):96.
   PubMedGoogle Scholar
• Saliba M, Shalhoub A, Taraif S, et al. Cutaneous leishmaniasis: an evolving disease with ancient roots. Int J Dermatol. 2019;58(7):834.
   PubMed Web of Science ®Google Scholar
• Bamorovat M, Sharifi I, Aflatoonian MR, et al. Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran. PLoS One 2018;13(2):e0192236.
   PubMed Web of Science ®Google Scholar
• Rasti S, Ghorbanzadeh B, Kheirandish F, et al. Comparison of molecular, microscopic, and culture methods for diagnosis of cutaneous leishmaniasis. J Clin Lab Anal. 2016;30(5):610–615.
   PubMed Web of Science ®Google Scholar
• Al-Hucheimi SN, Sultan BA, Al-Dhalimi MA. A comparative study of the diagnosis of Old World cutaneous leishmaniasis in Iraq by polymerase chain reaction and microbiologic and histopathologic methods. Int J Dermatol. 2009;48(4):404–408.
   PubMed Web of Science ®Google Scholar
• Karamian M, Motazedian M, Fakhar M, et al. Atypical presentation of Old‐World cutaneous leishmaniasis, diagnosis and species identification by PCR. J Eur Acad Dermatol Venereol. 2008;22(8):958–962.
   PubMed Web of Science ®Google Scholar
• Taslimi Y, Sadeghipour P, Habibzadeh S, et al. A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis. PLoS Negl Trop Dis. 2017;11(7):e0005750.
   PubMed Web of Science ®Google Scholar
• Ponte-Sucre A, Diaz E, Padron-Nieves M, editors. Drug resistance in leishmania parasites. Berlin, Germany: Springer; 2013.
   Google Scholar